Scar Prevention Clinical Trial
Official title:
Efficacy of Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention
The scar site was divided into 3 sites; combined IPL/fractional Er:YAG laser treatment site, fractional Er:YAG laser treatment site and untreated control site. At baseline, three lesions were randomized to IPL / fractional Er:YAG laser combination therapy site, fractional Er:YAG laser treatment alone site, and untreated control site. The laser treatment was conducted total three sessions, immediately at suture removal (baseline), 4 weeks after suture removal and 8 weeks after suture removal. The evaluation of scar site was conducted 3 months later after last treatment (20 weeks after suture removal).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00892723 -
A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars
|
Phase 2 | |
Active, not recruiting |
NCT06312527 -
Mepiform in Simultaneous Bilateral TKA
|
N/A | |
Completed |
NCT00825916 -
A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars
|
Phase 2 | |
Completed |
NCT01640912 -
Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109
|
Phase 1 | |
Completed |
NCT04707131 -
A Study of Single Ascending Dose of LEM-S401 in Healthy Participants
|
Phase 1 | |
Terminated |
NCT01826942 -
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
|
N/A | |
Completed |
NCT00811577 -
A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients
|
Phase 2 | |
Completed |
NCT01037985 -
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
|
Phase 2 | |
Completed |
NCT01037413 -
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery
|
Phase 2 | |
Completed |
NCT01780077 -
Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109
|
Phase 1 | |
Completed |
NCT01038297 -
Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
|
Phase 2 |